These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17430075)

  • 21. Anti-Rh17 (anti-Hr0): a rare diagnostic and management problem.
    Salamat N; Bhatti FA; Hussain A; Ziaullah
    J Pak Med Assoc; 2004 Apr; 54(4):215-8. PubMed ID: 15242002
    [No Abstract]   [Full Text] [Related]  

  • 22. Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.
    Isojima S; Hisano M; Suzuki T; Sago H; Murashima A; Yamaguchi K
    J Clin Apher; 2011; 26(4):216-8. PubMed ID: 21506141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serological conflict: relation between antibody titer, Liley's zone and the condition of the fetus and newborn infant].
    Czeszyńska M; Zieliński M; Czajkowski Z; Hnatyszyn G
    Acta Haematol Pol; 1991; 22(2):279-89. PubMed ID: 1841500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of pregnancy complicated by anti-hrB/anti-HrB.
    Win N; Needs M; Tillyer L
    Immunohematology; 2007; 23(4):143-5. PubMed ID: 18284303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic laboratory technologies for the fetus and neonate with isoimmunization.
    Geaghan SM
    Semin Perinatol; 2011 Jun; 35(3):148-54. PubMed ID: 21641488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.
    Mimura K; Endo M; Takahashi A; Doi Y; Sakuragi M; Kiyokawa T; Taniguchi H; Kitabatake Y; Handa M; Tomimatsu T; Tomiyama Y; Isaka Y; Kimura T
    Int J Hematol; 2020 Jan; 111(1):149-154. PubMed ID: 31538326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blood group incompatible pregnancy].
    Okubo M; Maeda H; Suzuki M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():727-30. PubMed ID: 16111382
    [No Abstract]   [Full Text] [Related]  

  • 28. Hemolytic disease of the newborn due to combination of anti-E and anti-S in the first pregnancy.
    Kanra T; Tunçer M; Pirnar A
    Turk J Pediatr; 1983; 25(1):49-54. PubMed ID: 6417855
    [No Abstract]   [Full Text] [Related]  

  • 29. Exchange transfusion of least incompatible blood for severe hemolytic disease of the newborn due to anti-Rh17.
    Li BJ; Jiang YJ; Yuan F; Ye HX
    Transfus Med; 2010 Feb; 20(1):66-9. PubMed ID: 19725902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

  • 31. Hemolytic disease of the fetus and newborn caused by an antibody to a low-prevalence antigen, anti-SARA.
    Towns D; Hannon J; Hendry J; Barnes J; Goldman M
    Transfusion; 2011 Sep; 51(9):1977-9. PubMed ID: 21414007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemolytic disease of the fetus and newborn due to anti-Ge3: combined antibody-dependent hemolysis and erythroid precursor cell growth inhibition.
    Blackall DP; Pesek GD; Montgomery MM; Oza KK; Arndt PA; Garratty G; Shahcheraghi A; Denomme GA
    Am J Perinatol; 2008 Oct; 25(9):541-5. PubMed ID: 18720327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 34. [A case of severe hemolytic disease of the newborn due to anti-Dia antibody].
    Lee SM; Im SJ; Park SE; Lee EY; Kim HH
    Korean J Lab Med; 2007 Oct; 27(5):373-6. PubMed ID: 18094604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-anti-D antibodies in red-cell alloimmunization.
    Lobo GA; Nardozza LM; Camano L
    Int J Gynaecol Obstet; 2006 Aug; 94(2):139-40. PubMed ID: 16828096
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first-trimester screening (CME).
    Dajak S; Stefanović V; Capkun V
    Transfusion; 2011 Jul; 51(7):1380-8. PubMed ID: 21214583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-c antibodies as a cause of severe form of hemolytic disease of the newborn].
    Sławek Z; Stolarz E; Banaszkiewicz A; Walczak Z; Surowiec E
    Acta Haematol Pol; 1988; 19(1-2):71-4. PubMed ID: 3149113
    [No Abstract]   [Full Text] [Related]  

  • 38. Rare case of hemolytic death of the newborn due to anti-hr0 and anti-e.
    Gong Y; Ai Y; Zhou R
    J Obstet Gynaecol Res; 2011 May; 37(5):465-7. PubMed ID: 21208345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antenatal tests in the diagnosis and assessment of severity of haemolytic disease (Hd) of the fetus and newborn (hdn).
    Contreras M
    Vox Sang; 1994; 67 Suppl 3():207-10. PubMed ID: 7975494
    [No Abstract]   [Full Text] [Related]  

  • 40. Fatal hemolytic disease of a newborn due to anti-D in an Rh-positive Du variant mother.
    Lacey PA; Caskey CR; Werner DJ; Moulds JJ
    Transfusion; 1983; 23(2):91-4. PubMed ID: 6404025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.